Implementation of a mandatory donor RHD screening in Switzerland

Transfusion and Apheresis Science

Volumn 50, Issue 2, 2014, Pages 169-174

  Crottet, Sofia Lejon ^a   Henny, Christine ^a   Meyer, Stefan ^b   Still, Franziska ^a   Stolz, Martin ^a   Gottschalk, Jochen ^b   Neuenschwander, Kathrin ^b   Taleghani, Behrouz Mansouri ^c   Gowland, Peter ^a   Frey, Beat M ^b   Fontana, Stefano ^a   Hustinx, Hein ^a   Niederhauser, Christoph ^a   Gassner, Christoph ^b,d  

^a Blood Transfusion Service SRC Berne   (Switzerland)

^b Zurich Blood Transfusion Service SRC   (Switzerland)

^c Blood Transfusion Service SRC Ltd   (Switzerland)

^d Blood Transfusion Service Zurich Swiss Red Cross   (Switzerland)

Author keywords

Molecular RHD screening; National guidelines; Rhesus D

Indexed keywords

RHESUS D ANTIBODY; BLOOD GROUP RHESUS SYSTEM; RHO(D) ANTIGEN;

ANTIBODY SCREENING; BLOOD BANK; BLOOD DONOR; BLOOD SAFETY; BLOOD SAMPLING; BLOOD TRANSFUSION; CONTROLLED STUDY; COOMBS TEST; COST BENEFIT ANALYSIS; DNA EXTRACTION; ERYTHROCYTE; EXON; GENE MUTATION; HUMAN; HUMAN TISSUE; PHENOTYPE; PRACTICE GUIDELINE; RED CROSS; REVIEW; SCREENING TEST; SWITZERLAND; BLOOD GROUP RHESUS SYSTEM; BLOOD GROUP TYPING; DONOR SELECTION; FEMALE; GENETICS; LEGISLATION AND JURISPRUDENCE; MALE; PROCEDURES; STANDARDS;

BLOOD DONORS; BLOOD GROUPING AND CROSSMATCHING; DONOR SELECTION; FEMALE; HUMANS; MALE; RH-HR BLOOD-GROUP SYSTEM; SWITZERLAND;

EID: 84900507890     PISSN: 14730502     EISSN: 18781683     Source Type: Journal    
DOI: 10.1016/j.transci.2014.02.011     Document Type: Review

References (22)

1. Flegel W.A. Homing in on D antigen immunogenicity. Transfusion 2005, 45:466-468.
2. Garratty G. Do we need to be more concerned about weak D antigens?. Transfusion 2005, 45:1547-1551.
3. Westhoff C.M. Molecular genotyping for RHD: what (not) to do?. Transfusion 2007, 47:1337-1339.
4. Krog G.R., Clausen F.B., Berkowicz A., Jorgensen L., Rieneck K., Nielsen L.K., et al. Is current serologic RhD typing of blood donors sufficient for avoiding immunization of recipients?. Transfusion 2011, 51:2278-2285.
5. Wagner F.F. RHD PCR of D-negative blood donors. Transfusion Medicine and Hemotherapy: offizielles Organ der Deutschen Gesellschaft fur Transfusionsmedizin und Immunhamatologie 2013, 40:172-181.
6. Gassner C., Doescher A., Drnovsek T.D., Rozman P., Eicher N.I., Legler T.J., et al. Presence of RHD in serologically D-, C/E+ individuals: a European multicenter study. Transfusion 2005, 45:527-538.
7. Legler T.J., Maas J.H., Kohler M., Wagner T., Daniels G.L., Perco P., et al. RHD sequencing: a new tool for decision making on transfusion therapy and provision of Rh prophylaxis. Transfus Med 2001, 11:383-388.
8. Gassner C., Meyer S., Frey B.M., Vollmert C. Matrix-assisted laser desorption/ionisation, time-of-flight mass spectrometry-based blood group genotyping - the alternative approach. Transfus Med Rev 2013, 27:2-9.
9. Gassner C., Schmarda A., Kilga-Nogler S., Jenny-Feldkircher B., Rainer E., Muller T.H., et al. RHD/CE typing by polymerase chain reaction using sequence-specific primers. Transfusion 1997, 37:1020-1026.
10. Polin H., Danzer M., Hofer K., Gassner W., Gabriel C. Effective molecular RHD typing strategy for blood donations. Transfusion 2007, 47:1350-1355.
11. Flegel W.A., Khull S.R., Wagner F.F. Primary anti-D immunization by weak D type 2 RBCs. Transfusion 2000, 40:428-434.
12. Mota M., Fonseca N.L., Rodrigues A., Kutner J.M., Castilho L. Anti-D alloimmunization by weak D type 1 red blood cells with a very low antigen density. Vox Sang 2005, 88:130-135.
13. Wagner T., Kormoczi G.F., Buchta C., Vadon M., Lanzer G., Mayr W.R., et al. Anti-D immunization by DEL red blood cells. Transfusion 2005, 45:520-526.
14. Yasuda H., Ohto H., Sakuma S., Ishikawa Y. Secondary anti-D immunization by Del red blood cells. Transfusion 2005, 45:1581-1584.
15. Ansart-Pirenne H., Asso-Bonnet M., Le Pennec P.Y., Roussel M., Patereau C., Noizat-Pirenne F. RhD variants in Caucasians: consequences for checking clinically relevant alleles. Transfusion 2004, 44:1282-1286.
16. Flegel W.A., Curin-Serbec V., Delamaire M., Donvito B., Ikeda H., Jorgensen J., et al. Section 1B: Rh flow cytometry. Coordinator's report. Rhesus index and antigen density: an analysis of the reproducibility of flow cytometric determination. Transfusion clinique et biologique: Journal de la Societe francaise de transfusion sanguine 2002, 9:33-42.
17. Wagner F.F., Frohmajer A., Flegel W.A. RHD positive haplotypes in D negative Europeans. BMC Genet 2001, 2:10.
18. Flegel W.A., von Zabern I., Wagner F.F. Six years' experience performing RHD genotyping to confirm D- red blood cell units in Germany for preventing anti-D immunizations. Transfusion 2009, 49:465-471.
19. Polin H., Danzer M., Gaszner W., Broda D., St-Louis M., Proll J., et al. Identification of RHD alleles with the potential of anti-D immunization among seemingly D- blood donors in Upper Austria. Transfusion 2009, 49:676-681.
20. Christiansen M., Sorensen B.S., Grunnet N. RHD positive among C/E+ and D- blood donors in Denmark. Transfusion 2010, 50:1460-1464.
21. Orzinska A., Guz K., Polin H., Pelc-Klopotowska M., Bednarz J., Gielezynska A., et al. RHD variants in Polish blood donors routinely typed as D. Transfusion 2013.
22. Li Q., Hou L., Guo Z.H., Ye L.Y., Yue D.Q., Zhu Z.Y. Molecular basis of the RHD gene in blood donors with DEL phenotypes in Shanghai. Vox Sang 2009, 97:139-146.